Br. Vohr et al., EFFECTS OF MATERNAL GESTATIONAL DIABETES AND ADIPOSITY ON NEONATAL ADIPOSITY AND BLOOD-PRESSURE, Diabetes care, 18(4), 1995, pp. 467-475
Citations number
30
Categorie Soggetti
Endocrynology & Metabolism","Medicine, General & Internal
OBJECTIVE -- To determine the effects of maternal factors, including p
repregnancy maternal adiposity, weight gain during pregnancy, degree o
f abnormality of the glucose tolerance test, glycemia during pregnancy
, and treatment with insulin versus diet therapy, on neonatal body wei
ght, adiposity, and blood pressure in infants of mothers with gestatio
nal diabetes (IGDM) and control patients. RESEARCH DESIGN AND METHODS-
A total of 119 term IGDM, including 57 large-for-gestational-age (LGA)
and 62 appropriate-for-gestational-age (AGA) infants, and 143 term co
ntrol infants, including 74 LGA and 69 AGA infants, were prospectively
enrolled. Maternal measurements of prepregnancy weight, height, and w
eight gain were abstracted from medical records. A diagnosis of gestat
ional diabetes was made on the basis of an initial 1-h 50-g glucose sc
reen value greater than or equal to 130 mg/dl followed by two abnormal
values in a 100-g oral glucose tolerance test. Infant anthropometric
measurements were obtained, and blood pressure was measured on day 2 o
f life. Correlation analyses and multiple regression analyses were per
formed to assess the relationships among maternal factors and neonatal
adiposity and blood pressure. RESULTS-Multiple regression analyses to
determine the effects of significant maternal factors on infant body
mass index (BMI) revealed that prepregnancy weight and weight gain wer
e significant predictors for both IGDM and control infants. An increas
ed glucose screen predicted BMI for control subjects, whereas the mean
2nd and 3rd trimester glucose values were the significant predictors
for IGDM. Also, increased newborn triceps skinfold thickness measureme
nts correlated with increased systolic blood pressure for IGDM (r = 0.
29, P < 0.03). CONCLUSIONS-Increased maternal prepregnancy weight, wei
ght gain in pregnancy, and glycemia in pregnancy all place IGDM at inc
reased risk of macrosomia and adiposity. Increased adiposity in the IG
DM appears to be related to increased infant blood pressure. Longitudi
nal evaluation is needed to determine whether neonatal adiposity in IG
DM is predictive of increased adiposity and blood pressure during chil
dhood.